Texting to Reduce Human Immunodeficiency Virus (HIV) Risk
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Boston University
- Study ID
- NCT06088277
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- TM HIV — BEHAVIORALParticipants will receive 5 intervention text messages (TM) about HIV risk and testing per week for the first 3 months and 3 messages per week for the last 3 months of the intervention.
- TM HL — BEHAVIORALParticipants will receive 5 intervention text messages (TM) about promoting healthy living (HL) per week for the first 3 months and 3 messages per week for the last 3 months of the intervention.
Study Details
This is a 3-year study to test the efficacy of a text message-based intervention program. Dental patients at 4 community health centers (n= 266) will be randomized to receive either text messages (TMs) regarding HIV prevention or TMs regarding overall wellness. Prior to enrolling the 266 participants, the investigators will conduct a feasibility pilot (n=20) to test the TM delivery as well as all study procedures. For both the pilot and the randomized clinical trial (RCT), recruitment will be conducted at 4 Community Health Center dental clinics (Codman Square, East Boston (both East Boston and South End locations), Geiger Gibson, and Upham's Community Health Centers). Recruitment materials (flyers and permission to contact forms) may also be made available at other clinics within the health centers. The study will enroll English and Spanish-speaking patients who have at least one risk factor for HIV but are HIV-negative. Patients enrolled in the pilot will complete self-report surveys at baseline, 1 and 2 months. Participants enrolled in the RCT will complete self-report surveys baseline, 3, 6, and 12 months after baseline; receive and respond to TM assessments during the 6-month intervention.
Key Dates
- Start date
- Aug 16, 2024
- Status verified
- Jul 2025
- Primary completion
- Apr 14, 2027
- Completion
- Apr 14, 2027
Study Design
- Enrollment
- 266 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: HIV text messages (TM HIV)Eligible participants randomized into this arm will receive text messages to reduce the risk for HIV and promote HIV testing.
- Active Comparator: TM HLEligible participants randomized into this arm will receive text messages to promote healthy living, but not specific to HIV risk or testing..
Primary Outcome Measure
Number of participants that obtain HIV testing [ Time Frame: 12 months ]
Central Contacts
- Michelle Henshaw, DDS, MPH:617-358-6111
- Gabriel Federo Hungria, MD, MSCR617-358-6490
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| East Boston Neighborhood Health Center | Boston | Massachusetts | 02128 | Mina Paul, DMD |
| South End Community Health Center | Boston | Massachusetts | 02118 | Mina Paul, DMD |
Find similar trials in Boston, MA
Related Studies
- Transmaculine One-on-One and Group Empowerment for Targeted HIV ReductionNot Yet Recruiting · Fenway Community Health · Boston, Massachusetts
- Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706PHASE1 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · San Francisco, California
- Infectious Disease (ID) Testing OUtreach in Carceral HubsRecruiting · Boston Medical Center · Boston, Massachusetts
- A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1PHASE3 · Recruiting · ViiV Healthcare · Birmingham, Alabama